Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Other Non-Current Assets (2022 - 2025)

GE HealthCare Technologies' Other Non-Current Assets history spans 4 years, with the latest figure at $120.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 14.29% year-over-year to $120.0 million, compared with a TTM value of $120.0 million through Dec 2025, up 14.29%, and an annual FY2025 reading of $120.0 million, up 14.29% over the prior year.
  • Other Non-Current Assets for Q4 2025 was $120.0 million at GE HealthCare Technologies, down from $2.2 billion in the prior quarter.
  • The five-year high for Other Non-Current Assets was $2.2 billion in Q3 2025, with the low at $81.0 million in Q1 2023.
  • Average Other Non-Current Assets over 4 years is $1.1 billion, with a median of $1.9 billion recorded in 2024.
  • Biggest YoY gain for Other Non-Current Assets was 2218.52% in 2024; the steepest drop was 95.28% in 2024.
  • Tracing GEHC's Other Non-Current Assets over 4 years: stood at $82.0 million in 2022, then rose by 17.07% to $96.0 million in 2023, then grew by 9.38% to $105.0 million in 2024, then grew by 14.29% to $120.0 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Other Non-Current Assets are $120.0 million (Q4 2025), $2.2 billion (Q3 2025), and $2.1 billion (Q2 2025).